Obese patients are at more risk of coming with complications including high blood pressure, type two diabetes, high cholesterol levels, stroke, and certain types of cancer
The MHRA update is simply a reminder that powerful drugs require powerful vigilance, and until we have larger, long-duration real-world safety data, clinicians should err on the side of specificity in monitoring and patients should be taught exactly what to look for. Hector Perez, MD
That is a fundamental principle in pharmacology, and it applies here
11 Importantly, the findings for the primary end point were generally consistent across various methods of handling missing data
If youre interested in GLP-1 medication, its better to talk to your doctor about how to move forward